N/A N=38 Randomized Single-blind Other

Effect of Snacks on Appetite Control

Healthy Canadians · Appetite Control

Bottom Line

View on ClinicalTrials.gov: NCT01806688 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2021

Primary outcome: Primary: Total Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS) — 651; 1008; 638; 640 cm x min — p=<0.05

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: gluten-free high protein snack #1 (Other); gluten-free snack with similar energy density but 1/2 the protein as snack #1 (Other); non-caloric control (Other); gluten-free high protein and high fibre snack #2 (Other); gluten-free snack with similar energy density, but less protein and fibre than snack #2 (Other)
Age: Adult, Older Adult · 20+ yrs
Sex: All
Sponsor: St. Boniface Hospital
Primary completion: Aug 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Total Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)	651; 1008; 638; 640; 636; 1024	<0.05 sig
SECONDARY Number of Calories Consumed Post-snack Until Bedtime	1429; 1326; 1288; 1448; 1414; 1478	<0.05 sig

Summary

This clinical trial is being conducted to study whether eating certain snacks will reduce your desire to eat and for a longer period of time compared to other snacks. The investigators are testing 2 different snacks. Study #1 will involve eating 2 different seed-like snacks or water. Study #2 will involve eating pita bread with jam, bread with jam or water. The test snack is higher in protein and/or fibre compared to the reference product.

Eligibility Criteria

Inclusion Criteria

Body mass index 18-30kg/m2
males and non-pregnant or non-lactating females

Exclusion Criteria

Diagnosis of disease by a medical doctor that requires medical treatment during the study period.
Daily tobacco use.
Physical Activity Level >1.8.
Eat meals at irregular or unusual times.
Food allergy, aversion or unwillingness to eat study foods.
Use of any prescription or non-prescription drug, herbal or nutritional supplement known to affect appetite.
Presence of a gastrointestinal disorder.
Score >65% on any 1 of the 3 categories of the Three Factor Eating Questionnaire-R18.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01806688). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.